
Lisinopril
Lisinopril
- SKU
- 68071-5036
- UPC
- 0368071503616
- Mfr
- NuCare Pharmaceuticals,Inc.
100 tablet in 1 bottle
$304.39
61 packs × $4.99 each
Minimum order: 61 packs. Each product is sold in quantities worth at least $300.00.
Prescription required. Upload your prescription at checkout or email it to us after ordering. We ship once a pharmacist has checked it. How it works
1 Hypertension Lisinopril tablets are indicated for the treatment of hypertension in adult patients and pediatric patients 6 years of age and older to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions.
- Strength
- Lisinopril 20 mg/1
- Unit of measure
- Per 1 tablet
- Dosage form
- Tablet
- Route
- Oral
Pharmacologic class
- Angiotensin Converting Enzyme InhibitorEstablished class
- Angiotensin-converting Enzyme InhibitorsMechanism
- Brand name
- Lisinopril
- Generic name
- Lisinopril
- Manufacturer
- NuCare Pharmaceuticals,Inc.
- Product NDC (SKU)
- 68071-5036
- UPC
- 0368071503616
- Active ingredients
- Lisinopril 20 mg/1
- Unit of measure
- Per 1 tablet
- Dosage form
- Tablet
- Route
- Oral
- DEA schedule
- Not controlled
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application number
- ANDA076059
- Marketed since
- July 1, 2002
- Label revised
- June 19, 2024
| Package NDC | Description |
|---|---|
| 68071-5036-1 | 100 TABLET in 1 BOTTLE |
Reading this NDC
68071-5036-1
- 01Labeler code
- NuCare Pharmaceuticals,Inc.
- 02Product code
- Lisinopril, tablet
- 03Package code
- 100 tablet in 1 bottle
Lisinopril inhibits angiotensin-converting enzyme (ACE) in human subjects and animals. ACE is a peptidyl dipeptidase that catalyzes the conversion of angiotensin I to the vasoconstrictor substance, angiotensin II. Angiotensin II also stimulates aldosterone secretion by the adrenal cortex. The beneficial effects of lisinopril in hypertension and heart failure appear to result primarily from suppression of the renin-angiotensin-aldosterone system.
Inhibition of ACE results in decreased plasma angiotensin II which leads to decreased vasopressor activity and to decreased aldosterone secretion. The latter decrease may result in a small increase of serum potassium. In hypertensive patients with normal renal function treated with lisinopril alone for up to 24 weeks, the mean increase in serum potassium was approximately 0.1 mEq/L; however, approximately 15% of patients had increases greater than 0.5 mEq/L and approximately 6% had a decrease greater than 0.5 mEq/L. In the same study, patients treated with lisinopril and hydrochlorothiazide for up to 24 weeks had a mean decrease in serum potassium of 0.1 mEq/L; approximately 4% of patients had increases greater than 0.5 mEq/L and approximately 12% had a decrease greater than 0.5 mEq/L. Removal of angiotensin II negative feedback on renin secretion leads to increased plasma renin activity.
ACE is identical to kininase, an enzyme that degrades bradykinin. Whether increased levels of bradykinin, a potent vasodepressor peptide, play a role in the therapeutic effects of lisinopril remains to be elucidated. While the mechanism through which lisinopril lowers blood pressure is believed to be primarily suppression of the renin angiotensin-aldosterone system, lisinopril is antihypertensive even in patients with low-renin hypertension.
Although lisinopril was antihypertensive in all races studied, Black hypertensive patients (usually a low-renin hypertensive population) had a smaller average response to monotherapy than non Black patients. Concomitant administration of lisinopril and hydrochlorothiazide further reduced blood pressure in Black and non-Black patients and any racial differences in blood pressure response were no longer evident.
Warning: Fetal toxicity
When pregnancy is detected, discontinue l isinopril as soon as possible. Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus. WARNING: FETAL TOXICITY See full prescribing information for complete boxed warning. When pregnancy is detected, discontinue lisinopril tablets as soon as possible.
Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus.
Lisinopril tablets are an angiotensin converting enzyme (ACE) inhibitor indicated for: Treatment of hypertension in adults and pediatric patients 6 years of age and older
Adjunct therapy for heart failure
Treatment of Acute Myocardial Infarction
Hypertension
Lisinopril tablets are indicated for the treatment of hypertension in adult patients and pediatric patients 6 years of age and older to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes.
Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than 1 drug to achieve blood pressure goals. For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program’s Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC).
Numerous antihypertensive drugs, from a variety of pharmacologic classes and with different mechanisms of action, have been shown in randomized controlled trials to reduce cardiovascular morbidity and mortality, and it can be concluded that it is blood pressure reduction, and not some other pharmacologic property of the drugs, that is largely responsible for those benefits.
The largest and most consistent cardiovascular outcome benefit has been a reduction in the risk of stroke, but reductions in myocardial infarction and cardiovascular mortality also have been seen regularly. Elevated systolic or diastolic pressure causes increased cardiovascular risk, and the absolute risk increase per mmHg is greater at higher blood pressures, so that even modest reductions of severe hypertension can provide substantial benefit.
Relative risk reduction from blood pressure reduction is similar across populations with varying absolute risk, so the absolute benefit is greater in patients who are at higher risk independent of their hypertension (for example, patients with diabetes or hyperlipidemia), and such patients would be expected to benefit from more aggressive treatment to a lower blood pressure goal.
Some antihypertensive drugs have smaller blood pressure effects (as monotherapy) in black patients, and many antihypertensive drugs have additional approved indications and effects (e.g., on angina, heart failure, or diabetic kidney disease). These considerations may guide selection of therapy. Lisinopril tablets may be administered alone or with other antihypertensive agents.
Heart Failure
Lisinopril tablets are indicated to reduce signs and symptoms of systolic heart failure.
Reduction of Mortality in Acute Myocardial Infarction
Lisinopril tablets are indicated for the reduction of mortality in treatment of hemodynamically stable patients within 24 hours of acute myocardial infarction. Patients should receive, as appropriate, the standard recommended treatments such as thrombolytics, aspirin and beta-blockers.
Read before you order

Heart health · 2 min read
Blood pressure medicines explained: ACE inhibitors, ARBs, amlodipine and more
How lisinopril, losartan, amlodipine, hydrochlorothiazide and metoprolol lower blood pressure, and their most common side effects.

Heart health · 2 min read
Statins and cholesterol: how atorvastatin protects your heart
How statins lower LDL cholesterol, who benefits, the truth about muscle aches and what to avoid while taking atorvastatin.

Heart health · 2 min read
Taking apixaban safely: a guide to blood thinners
Why apixaban is prescribed, how to take it twice a day, bleeding signs to watch for and medicines to avoid.
More in Cardiac
View all
Generic · Tablet
Amlodipine Besylate
Amlodipine Besylate 10 mg/1
- SKU
- 67046-1157
- Mfr
- Coupler LLC
From $4.99Min. 61 packs

Generic · Tablet
Amlodipine Besylate
Amlodipine Besylate 10 mg/1
- SKU
- 67296-2297
- Mfr
- Redpharm Drug
From $4.99Min. 61 packs

Generic · Tablet
Atorvastatin Calcium
Atorvastatin Calcium Trihydrate 20 mg/1
- SKU
- 67046-1403
- Mfr
- Coupler LLC
From $4.99Min. 61 packs

Generic · Tablet
Atorvastatin Calcium
Atorvastatin Calcium Trihydrate 10 mg/1
- SKU
- 67046-1677
- Mfr
- Coupler LLC
From $4.99Min. 61 packs